Psychological and Psychopharmacological Interventions in Psychocardiology
Patients with mental disorders have an increased risk to develop cardiovascular disease (CVD), and CVD are frequently comorbid with especially adjustment, anxiety and depressive disorders. Therefore, clinicians need to be aware of effective and safe psychological and pharmacological treatment strate...
Main Authors: | Kai G. Kahl, Britta Stapel, Christoph U. Correll |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.831359/full |
Similar Items
-
Psychocardiology in a heartbeat: cardiac complications to consider in psychopharmacology
by: M. Conde Moreno, et al.
Published: (2022-06-01) -
Editorial: Community series in psychocardiology: exploring the brain-heart interface - Volume II
by: Marlies E. Alvarenga, et al.
Published: (2024-06-01) -
The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in Austria
by: M. Otter, et al.
Published: (2024-01-01) -
Elements of psychocardiology in the psychosocial handling of adults with congenital heart disease
by: Edward Callus, et al.
Published: (2010-08-01) -
Beyond One-Size-Fits-All: Personalized Medicine and Future Directions in Sex-Based Psychopharmacological Treatment
by: Marianna Mazza, et al.
Published: (2024-08-01)